Moderna’s stock soars 10% to lead S&P 500 gainers as Oppenheimer upgrades to buy

Moderna’s stock started the year with a bang thanks to an analyst upgrade.

Previous post AMC CEO slams ‘prophets of doom,’ says company is ‘blazing new trails’ as it enters 2024
Next post U.S. construction spending rises for 11th month in a row in November